Research on the price difference and regional distribution of selected drugs in Chinas centralized procurement

Corresponding author: Luo Li, liluo@fudan.edu.cn

DOI: 10.12201/bmr.202306.00008

•  

  Abstract: Objective: To analyze the difference and regional distribution of the prices of selected drugs in Chinas centralized procurement with quantity, and to put forward policy suggestions to promote more reasonable prices of selected drugs; Methods: The ratio and range were used to compare the price differences of selected drugs, and the regional distribution of drug prices was described by the national product virtual method. Results: From the perspective of price difference, there were cases in the selection results that the minimum comparable price difference of the same generic name drug exceeded 50 yuan and the ratio of the highest price to the lowest price exceeded 1.8. From the perspective of regional distribution, the distribution of selected drugs shows the phenomenon of low prices in economically developed areas and high prices in economically underdeveloped areas. Conclusion: The prices of some selected drugs vary greatly, and the regional distribution and economic level of selected drugs are inverted. It is suggested to play the role of renewal procurement to narrow the drug price gap, and introduce secondary inquiry to promote interregional drug price fairness.

  Key words: National centralized drug; Drug price；Regional distribution

  Submit time: 5 June 2023

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Sun Yan, Zhu Zheng, Yang Li. Influencing factors analysis on price reduction in national volume-based drug procurement.. 2022. doi: 10.12201/bmr.202203.00008

  WangBiao, Zhang Tiantian, Tang Xiaoyu, Jia Yun, Luo Li. A study of price reduction sustainability in national volume-based drug procurement. 2023. doi: 10.12201/bmr.202305.00008

  SUN Wenjun, ZHAO Ziyin, CHENG Zheyu, LI Huining, ZHU He. Impact of the national centralized drug procurement policy on drug prices and utilization: a systematic review. 2023. doi: 10.12201/bmr.202303.00033

  songjia, fanchengxin, wangwanchen, aixufeng, liuxinlu, licuiyu, zhangyujie, liqiusha, wanganqi, fengzhiqiang, yinwenqiang, madongping. Study on Chinas centralized quantity purchasing policy for drugs from the perspective of stakeholders - a textual analysis based on policy tools. 2022. doi: 10.12201/bmr.202203.00006

  LIU MINGZHU, LU YUN. Research on the Implementation Effect of Expiration of National Pharmaceutical Centralized Volume-based Procurement Based on Intermittent Time Series: A Case Study of Hebei Province. 2023. doi: 10.12201/bmr.202306.00007

  LI Zhao, Zhao Ke, Zhou Lulin, Chen Sheng. Research on the Comparison and Development Countermeasures of Pharmaceutical Group Purchasing Modes from the Perspective of the Normalization of National Centralized Procurement. 2021. doi: 10.12201/bmr.202109.00037

  Tang Yuqing, Li Yinming, Chen Xizhuo, Xue Tianqin, Chen Hao. Analysis of the Execution of Centralized Drug Procurement Policy Based on Policy Implementation System Model. 2023. doi: 10.12201/bmr.202310.00002

  HAN Meng, WANG Shi-jia, HU Hao-yu, ZHAO Yan-jiao, CHEN Yong-fa. Comparative Study on Grouping Rules in Centralized Volume-based Procurement of Chinese Patent Medicine. 2023. doi: 10.12201/bmr.202312.00008

  YU Chen, HOU Jian-lin, WANG Dan, XIE A-na, WANG Wei-min. Analysis on the distribution and regional difference of medical undergraduate colleges in China. 2021. doi: 10.12201/bmr.202104.00021

  wangennan, zhuminglai. Evolutionary Game Research on Price Negotiation of Patent Medicine Medical Insurance in China. 2023. doi: 10.12201/bmr.202303.00032

• ID	Submit time	Number	Download
  1	2023-03-27	bmr.202306.00008V1	Download

• Public  Anonymous  To author only Submit Comments